RPS6KB1 and cervical cancer: The S6K1 inhibitor RAME, which blocks the interaction between S6K1 and mTOR, promoted autophagy and apoptosis and greatly enhanced the antitumor effect of cisplatin in cisplatin-resistant cervical cancer cells [59].